Exkivity is an oral tyrosine kinase inhibitor (TKI). The Exkivity version produced by Lucius has a specification of 40mg * 120 pills and is currently priced at $621.
The price of Exkivity may be influenced by various factors, including production costs and market demand.
What is Exkivity?Molablotinib is a novel EGFR-TKI (epidermal growth factor recep···【more】
Release date:2024-11-29Recommended:166
The price of Exkivity varies depending on a number of factors, including the ver···【more】
Release date:2024-08-06Recommended:188
Exkivity is an orally targeted drug targeting EGFR gene mutations for the treatm···【more】
Release date:2024-08-06Recommended:207
Exkivity is a targeted therapy for specific types of non-small cell lung cancer ···【more】
Release date:2024-08-06Recommended:198